Shanghai Micurx Pharmaceutical Co., Ltd. Class ASSE: 688373

"SHANGHAI MICURX PHARMACEUTICAL CO., LTD."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry

Sep 5, 2026 · Issued by Shanghai Micurx Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Shanghai Micurx Pharmaceutical Co., Ltd. Class A

"SHANGHAI MICURX PHARMACEUTICAL CO., LTD."Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026Aug 26
"SHANGHAI MICURX PHARMACEUTICAL CO., LTD."Announcement on Continued Use of Idle Raised Funds for Cash ManagementJul 28
"SHANGHAI MICURX PHARMACEUTICAL CO., LTD."Announcement on Resignation of Securities Affairs RepresentativeJul 8
Announcement on Listing and Circulation of Partial Restricted Shares in Initial Public OfferingJun 23

All Shanghai Micurx Pharmaceutical Co., Ltd. Class A news releases